LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 105 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,091 | -24.0% | 28,043 | -9.2% | 0.00% | – |
| Q2 2023 | $43,556 | -6.0% | 30,891 | 0.0% | 0.00% | – |
| Q1 2023 | $46,337 | +50.6% | 30,891 | +17.5% | 0.00% | – |
| Q4 2022 | $30,760 | +2.5% | 26,291 | -0.3% | 0.00% | – |
| Q3 2022 | $30,000 | -28.6% | 26,368 | +0.3% | 0.00% | – |
| Q2 2022 | $42,000 | +7.7% | 26,302 | +2.8% | 0.00% | – |
| Q1 2022 | $39,000 | -32.8% | 25,581 | +8.5% | 0.00% | – |
| Q4 2021 | $58,000 | -9.4% | 23,581 | -7.7% | 0.00% | – |
| Q3 2021 | $64,000 | -9.9% | 25,558 | +2.2% | 0.00% | – |
| Q2 2021 | $71,000 | -74.1% | 25,000 | -78.5% | 0.00% | -100.0% |
| Q1 2021 | $274,000 | +33.7% | 116,453 | 0.0% | 0.00% | – |
| Q4 2020 | $205,000 | +88.1% | 116,453 | -0.0% | 0.00% | – |
| Q3 2020 | $109,000 | -9.9% | 116,454 | -16.0% | 0.00% | – |
| Q2 2020 | $121,000 | +39.1% | 138,697 | +31.9% | 0.00% | – |
| Q1 2020 | $87,000 | -48.5% | 105,116 | -44.5% | 0.00% | -100.0% |
| Q4 2019 | $169,000 | -15.9% | 189,367 | -7.7% | 0.00% | 0.0% |
| Q3 2019 | $201,000 | – | 205,182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,005,379 | $85,694,000 | 4.37% |
| Defender Capital, LLC. | 4,798,270 | $12,707,000 | 4.13% |
| Raffles Associates | 93,590 | $236,000 | 0.22% |
| Prescott General Partners LLC | 1,851,851 | $4,667,000 | 0.16% |
| DCF Advisers, LLC | 87,000 | $219,000 | 0.10% |
| Laidlaw Wealth Management LLC | 104,841 | $264,000 | 0.07% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $113,000 | 0.06% |
| Strategic Wealth Investment Group, LLC | 70,625 | $179,000 | 0.05% |
| Fort Sheridan Advisors LLC | 47,931 | $121,000 | 0.04% |
| Sightline Wealth Advisors, LLC | 14,958 | $38,000 | 0.03% |